Publication | Closed Access
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
179
Citations
10
References
2010
Year
We suggest that gammadelta T-cell immunotherapy might be safe and feasible for patients with recurrent non-small-cell lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1